or
forgot password
  • cancer clinical trials in connecticut

  • Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    Middlesex Hospital
    The Hospital of Central Connecticut
    Eastern Connecticut Hematology and Oncology Associates
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Colorectal Cancer
    Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Cutaneous Lymphoma, Cutaneous T-cell Lymphoma
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    Yale University
    William Backus Hospital
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
    Oncology Associates PC
    Hartford, Connecticut 06106
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
    Joao Nascimento, MD
    Bridgeport, Connecticut 06606
    Psoriatic Arthritis
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    New Britain, Connecticut 06052
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Hematology Oncology Associates, P.C.
    Stamford, Connecticut 06902-3628
    Adenocarcinoma of the Lung
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Hematology Oncology, P.C.
    Stamford, Connecticut 06902
    Sickle Cell Disease
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Yale University
    New Haven, Connecticut 06520
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Middlesex Hospital Cancer Center
    Prostate Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Breast Cancer
    Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer
    Yale University School Of Medicine

    Trial Locations
    Yale University School Of Medicine
    The Whittingham Cancer Center, Norwalk Hospital
    Oral Mucositis
    BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study
    Yale Universtiy
    New Haven, Connecticut 06520
    Lung Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    An Intervention to Improve Outcomes in Patients With Advanced Cancer
    Yale New Haven Hospital/Smilow Cancer Hospital
    New Haven, Connecticut 06510
    Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Manchester Memorial Hospital
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    Midstate Medical Center
    The Hospital of Central Connecticut
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer